

(ShareCast News) - Hikma Pharmaceuticals's chief Said Darwazah boosted his stake in the generic drugs firm on Wednesday to 5.49% through the acquisiti...


(ShareCast News) - Hikma Pharmaceuticals' newest board member has bought himself some skin in the game, following his chief executive's lead. US publi...


(ShareCast News) - Hikma Pharmaceuticals said on Friday that its abbreviated new drug application for fluticasone propionate and salmeterol inhalation...